Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
- PMID: 17638928
- DOI: 10.1161/CIRCULATIONAHA.107.691972
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection
Abstract
Background: The landmark Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) trial first demonstrated that implantation of left ventricular assist devices (LVADs) as destination therapy (DT) can provide survival superior to any known medical treatment in patients with end-stage heart failure who are ineligible for transplantation. In the present study, we describe outcomes of DT in the post-REMATCH era in the United States.
Methods and results: The present study included 280 patients who underwent HeartMate XVE LVAD implantation between November 2001 and December 2005. A preoperative risk score for in-hospital mortality after LVAD implantation was established in 222 patients with complete data. All patients were followed up until death or December 2006. The 1-year survival after LVAD implantation was 56%. The in-hospital mortality after LVAD surgery was 27%. The main causes of death included sepsis, right heart failure, and multiorgan failure. The most important determinants of in-hospital mortality were poor nutrition, hematological abnormalities, markers of end-organ or right ventricular dysfunction, and lack of inotropic support. Stratification of DT candidates into low (n=65), medium (n=111), high (n=28), and very high (n=18) risk on the basis of the risk score calculated from these predictors corresponded with 1-year survival rates of 81%, 62%, 28%, and 11%, respectively.
Conclusions: Appropriate selection of candidates and timing of LVAD implantation are critical for improved outcomes of DT. Patients with advanced heart failure who are referred for DT before major complications of heart failure develop have the best chance of achieving an excellent 1-year survival with LVAD therapy.
Comment in
-
Mechanical circulatory support: new data, old problems.Circulation. 2007 Jul 31;116(5):461-2. doi: 10.1161/CIRCULATIONAHA.107.715300. Circulation. 2007. PMID: 17664383 No abstract available.
Similar articles
-
Improving outcomes with long-term "destination" therapy using left ventricular assist devices.J Thorac Cardiovasc Surg. 2008 Jun;135(6):1353-60; discussion 1360-1. doi: 10.1016/j.jtcvs.2006.09.124. J Thorac Cardiovasc Surg. 2008. PMID: 18544385
-
Impact of center volume on outcomes of left ventricular assist device implantation as destination therapy: analysis of the Thoratec HeartMate Registry, 1998 to 2005.Circ Heart Fail. 2009 Jan;2(1):3-10. doi: 10.1161/CIRCHEARTFAILURE.108.796128. Circ Heart Fail. 2009. PMID: 19808309 Clinical Trial.
-
Left ventricular assist device destination therapy versus extended criteria cardiac transplant.Ann Thorac Surg. 2010 Apr;89(4):1205-9; discussion 1210. doi: 10.1016/j.athoracsur.2009.12.058. Ann Thorac Surg. 2010. PMID: 20338335
-
Destination therapy: current results and future promise.Semin Thorac Cardiovasc Surg. 2008 Fall;20(3):225-33. doi: 10.1053/j.semtcvs.2008.08.004. Semin Thorac Cardiovasc Surg. 2008. PMID: 19038733 Review.
-
Left ventricular device as destination therapy: are we there yet?Curr Opin Cardiol. 2009 Mar;24(2):184-9. doi: 10.1097/HCO.0b013e328323f58f. Curr Opin Cardiol. 2009. PMID: 19532106 Review.
Cited by
-
Recovery of Serum Cholesterol Predicts Survival After Left Ventricular Assist Device Implantation.Circ Heart Fail. 2016 Sep;9(9):e002881. doi: 10.1161/CIRCHEARTFAILURE.115.002881. Circ Heart Fail. 2016. PMID: 27623768 Free PMC article.
-
Ventricular assist device selection: which one and when?Croat Med J. 2014 Dec;55(6):596-9. doi: 10.3325/cmj.2014.55.596. Croat Med J. 2014. PMID: 25559830 Free PMC article. Review.
-
Inhaled therapy for the management of perioperative pulmonary hypertension.Ann Card Anaesth. 2015 Jul-Sep;18(3):394-402. doi: 10.4103/0971-9784.159811. Ann Card Anaesth. 2015. PMID: 26139748 Free PMC article. Review.
-
Patient selection for mechanical circulatory support.Heart Fail Rev. 2013 Jan;18(1):27-34. doi: 10.1007/s10741-012-9316-0. Heart Fail Rev. 2013. PMID: 22544400 Review.
-
A new Bayesian network-based risk stratification model for prediction of short-term and long-term LVAD mortality.ASAIO J. 2015 May-Jun;61(3):313-23. doi: 10.1097/MAT.0000000000000209. ASAIO J. 2015. PMID: 25710772 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical